Incidence of osteonecrosis of the jaw in patients receiving denosumab or zoledronic acid for bone metastases from solid tumors or multiple myeloma: Results from three phase III trials.
Allan Lipton
Honoraria - Amgen
Research Funding - Amgen
Fred Saad
Consultant or Advisory Role - Amgen; Novartis
Honoraria - Amgen; Novartis
Research Funding - Amgen; Novartis
Catherine H. Van Poznak
Employment or Leadership Position - Bone and Cancer Foundation; Paget Foundation
Research Funding - NIH - NIDCR; Translational Breast Cancer Research Consortium
Other Remuneration - NCCN (Educational Presentation Development); School of Breast Oncology (Educational Presentation Development); UpToDate (Intellectual Property Interests); Western Michigan University School of Medicine (Educational Presentation Development)
Janet Elizabeth Brown
Consultant or Advisory Role - Amgen; Bristol-Myers Squibb; Novartis
Honoraria - Amgen; Novartis
Research Funding - Novartis
Alison Stopeck
Consultant or Advisory Role - Amgen
Honoraria - Amgen
Karim Fizazi
Consultant or Advisory Role - Amgen; Novartis
Honoraria - Amgen
David H. Henry
Consultant or Advisory Role - Amgen; Ortho Biotech; Watson Pharmaceuticals
Honoraria - Amgen; Ortho Biotech; Watson Pharmaceuticals
Research Funding - Amgen; Ortho Biotech; Watson Pharmaceuticals
Neal D. Shore
Consultant or Advisory Role - Amgen; Astellas Pharma; Bayer; Dendreon; Janssen; Medivation
Ingo J. Diel
Consultant or Advisory Role - Amgen; Novartis; Roche
Honoraria - Amgen; GlaxoSmithKline; Medtronic; Novartis; Roche; Teva
Katia Sonia Tonkin
No relevant relationships to disclose
Richard H. De Boer
Consultant or Advisory Role - Novartis
Honoraria - Novartis
Research Funding - Amgen; Novartis
Other Remuneration - Amgen; Novartis
Huei Wang
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Ada H. Braun
Employment or Leadership Position - Amgen
Stock Ownership - Amgen